Quadrature Capital
CPIX icon

Quadrature Capital’s Cumberland Pharmaceuticals CPIX Stock Holding History

Quadrature Capital’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-24,014
Closed -$156K – 2117
2026
Q2 		$156K Buy
+24,014
New +$115K ﹤0.01% 1410

Other funds holding CPIX

Diversified Trust
Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Quadrature Capital's CPIX Position: Q3 2026 in Review

Quadrature Capital sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2026, closing a stake of 24,014 shares — an estimated $156K sold.

Quadrature Capital first reported a position in CPIX in Q2 2026 and held it in 1 quarter. The position peaked at $156K in Q2 2026. 18 funds tracked by Wall St. Rank hold CPIX as of Q3 2026.

  • Quadrature Capital reported no remaining Cumberland Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Quadrature Capital sold 24,014 Cumberland Pharmaceuticals shares in Q3 2026, an estimated $156K.
  • Quadrature Capital first reported a position in Cumberland Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Quadrature Capital's Cumberland Pharmaceuticals position peaked at $156K in Q2 2026.
  • 18 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.

Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.